HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Carmine Zoccali Selected Research

paricalcitol (Zemplar)

2/2020FGF23 and the PTH response to paricalcitol in chronic kidney disease.
10/2018Circulating adiponectin modifies the FGF23 response to vitamin D receptor activation: a post hoc analysis of a double-blind, randomized clinical trial.
1/2017Vitamin D and methylarginines in chronic kidney disease (CKD).
11/2014Paricalcitol and endothelial function in chronic kidney disease trial.
12/2012Vitamin D reduces left atrial volume in patients with left ventricular hypertrophy and chronic kidney disease.
2/2012Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial.
4/2011The use of group sequential, information-based sample size re-estimation in the design of the PRIMO study of chronic kidney disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Carmine Zoccali Research Topics

Disease

88Chronic Kidney Failure (Chronic Renal Failure)
07/2020 - 01/2000
68Chronic Renal Insufficiency
01/2022 - 05/2003
48Inflammation (Inflammations)
07/2020 - 01/2002
43Hypertension (High Blood Pressure)
03/2022 - 03/2002
27Cardiovascular Diseases (Cardiovascular Disease)
05/2021 - 01/2002
22Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
03/2022 - 07/2002
20Atherosclerosis
05/2017 - 01/2002
18Renal Insufficiency (Renal Failure)
07/2022 - 01/2002
18Heart Failure
12/2021 - 07/2001
18Proteinuria
12/2020 - 01/2000
16Neoplasms (Cancer)
12/2021 - 05/2010
15Kidney Diseases (Kidney Disease)
12/2021 - 01/2002
14Insulin Resistance
12/2016 - 05/2003
11Essential Hypertension
08/2013 - 09/2002
10Weight Loss (Weight Reduction)
03/2022 - 11/2013
10Cardiomyopathies (Cardiomyopathy)
01/2017 - 06/2005
9Diabetes Mellitus
05/2021 - 02/2004
8Pain (Aches)
12/2021 - 01/2010
8Disease Progression
05/2021 - 05/2006
7Infections
12/2021 - 01/2003
7Obesity
10/2018 - 01/2005
7Malnutrition (Nutritional Deficiencies)
01/2018 - 02/2005
7Ischemia
01/2014 - 07/2002
6Albuminuria
05/2021 - 03/2008
6Vascular Calcification
01/2018 - 01/2004
6Anemia
12/2016 - 01/2003
5Chronic Kidney Disease-Mineral and Bone Disorder (Renal Rickets)
07/2022 - 01/2013
5Myocardial Infarction
12/2021 - 03/2008
5Wounds and Injuries (Trauma)
12/2021 - 02/2016
5Coronary Disease (Coronary Heart Disease)
11/2019 - 11/2005
5Liver Diseases (Liver Disease)
01/2018 - 12/2008
5Left Ventricular Dysfunction
10/2015 - 11/2002
5Carotid Artery Diseases
03/2015 - 12/2005
4Sarcoma (Soft Tissue Sarcoma)
08/2020 - 11/2018
4Hyperphosphatemia
07/2020 - 01/2004
4Hypertrophy
01/2020 - 07/2002
4Secondary Hyperparathyroidism
01/2019 - 01/2003
4Hyperhomocysteinemia
04/2005 - 02/2002
3Neoplasm Metastasis (Metastasis)
06/2022 - 08/2012
3Cognitive Dysfunction
12/2021 - 01/2020

Drug/Important Bio-Agent (IBA)

35C-Reactive ProteinIBA
11/2019 - 01/2002
33Biomarkers (Surrogate Marker)IBA
07/2022 - 07/2003
23N,N-dimethylarginine (asymmetric dimethylarginine)IBA
10/2015 - 01/2002
14Phosphates (Orthophosphate)IBA
07/2022 - 01/2006
14Nitric Oxide Synthase (NO Synthase)IBA
01/2013 - 01/2002
13Norepinephrine (Noradrenaline)FDA LinkGeneric
01/2021 - 03/2002
13Interleukin-6 (Interleukin 6)IBA
01/2019 - 01/2002
12Vitamin DFDA LinkGeneric
07/2022 - 01/2009
12Nitric Oxide (Nitrogen Monoxide)FDA Link
07/2020 - 01/2002
12Proteins (Proteins, Gene)FDA Link
01/2019 - 07/2002
10Antihypertensive Agents (Antihypertensives)IBA
12/2020 - 02/2004
10AdiponectinIBA
10/2018 - 01/2002
10Arginine (L-Arginine)FDA Link
01/2017 - 02/2004
10CytokinesIBA
11/2013 - 01/2002
9SodiumIBA
05/2021 - 01/2000
9Uric Acid (Urate)IBA
01/2018 - 05/2006
8Edetic Acid (EDTA)FDA Link
12/2021 - 03/2016
8Hemoglobins (Hemoglobin)IBA
08/2012 - 08/2005
8CreatinineIBA
10/2011 - 01/2002
7SaltsIBA
01/2022 - 09/2003
7Neuropeptide YIBA
12/2021 - 07/2003
7MineralsIBA
07/2020 - 05/2008
7paricalcitol (Zemplar)FDA Link
02/2020 - 04/2011
7Acetylcholine (Acetylcholine Chloride)FDA Link
10/2015 - 08/2004
6Pharmaceutical PreparationsIBA
01/2020 - 02/2011
6Calcitriol Receptors (Calcitriol Receptor)IBA
01/2019 - 02/2010
6AlbuminsIBA
01/2019 - 02/2005
6LeptinIBA
03/2017 - 05/2003
6Indicators and Reagents (Reagents)IBA
03/2016 - 09/2005
6Serum AlbuminIBA
01/2013 - 05/2003
6HomocysteineIBA
12/2010 - 01/2004
5CalciumIBA
07/2022 - 03/2015
5Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
11/2019 - 06/2008
5Ramipril (Altace)FDA LinkGeneric
01/2019 - 01/2000
5DiureticsIBA
12/2017 - 01/2000
5AldosteroneIBA
04/2017 - 01/2002
5CholesterolIBA
04/2017 - 05/2003
5Triiodothyronine (Liothyronine)FDA LinkGeneric
12/2016 - 07/2003
5Brain Natriuretic Peptide (Natrecor)FDA Link
10/2009 - 07/2001
4Alkaline PhosphataseIBA
11/2019 - 10/2015
4LipidsIBA
02/2019 - 04/2011
4ErythropoietinFDA Link
04/2017 - 04/2006
4Insulin (Novolin)FDA Link
12/2016 - 01/2011
4ProcalcitoninIBA
03/2016 - 03/2007
4Atrial Natriuretic Factor (ANF)IBA
12/2015 - 07/2001
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2015 - 01/2002
4urotensin IIIBA
03/2008 - 11/2005

Therapy/Procedure

52Renal Dialysis (Hemodialysis)
03/2022 - 02/2002
28Therapeutics
06/2022 - 08/2005
11Kidney Transplantation
01/2022 - 01/2013
8Transplantation
07/2022 - 01/2013
6Drug Therapy (Chemotherapy)
12/2021 - 03/2002
5Prostheses and Implants (Prosthesis)
12/2021 - 09/2009
5Renal Replacement Therapy (Therapies, Renal Replacement)
12/2020 - 12/2009
5Continuous Ambulatory Peritoneal Dialysis (CAPD)
01/2010 - 03/2004
4Ultrasonic Surgical Procedures
12/2021 - 08/2016
4Secondary Prevention
03/2021 - 09/2003
4Denervation
08/2017 - 09/2013
4Peritoneal Dialysis
04/2017 - 09/2012
3Debridement
08/2021 - 01/2015